Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical responders

International Journal of Cancer. Journal International Du Cancer
Susanne HofmannJochen Greiner

Abstract

T cell responses against malignant cells play a major role in maintaining remission and prolonging overall survival in patients after allogeneic stem cell transplantation and donor lymphocyte infusion (DLI) due to graft-versus-leukemia effect. For better characterization of the T cell responses, we assessed frequency and diversity of leukemia-associated antigen (LAA)-specific cytotoxic T cells using ELISpot and pMHC multimer assays and analyzed the frequency of regulatory T cells (Treg) as well as cytokine profiles before/after DLI. The data were correlated to the clinical course of patients. Significantly more LAA-derived T cell epitopes (p = 0.02) were recognized in clinical responders (R) when compared to nonresponders (NR). In addition, pMHC multimer-based flow cytometry showed a significantly higher frequency of LAA-specific T cells in R versus NR. The frequency of Treg in R decreased significantly (p = 0.008) while keeping stable in NR. No differences in T cell subset analysis before/after DLI were revealed. Clinical responders were correlated to specific immune responses and all clinical responders showed an increase of specific immune responses after DLI. Cytokine assays using enzyme-linked immunosorbent assay showed a ...Continue Reading

References

Apr 2, 2003·Nature Reviews. Immunology·Kimberly S Schluns, Leo Lefrançois
Sep 10, 2003·Experimental Hematology·J H Frederik FalkenburgRoel Willemze
Nov 25, 2003·Hematology·Helen E HeslopJeffrey J Molldrem
Feb 25, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Paul A AntonyNicholas P Restifo
May 21, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gerald P Morris, Paul M Allen
May 8, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jacqueline M Tarrant
Aug 10, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Adam W MaillouxPearlie K Epling-Burnette
Dec 19, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susanne HofmannJochen Greiner
Mar 1, 2013·Science Translational Medicine·Aude G ChapuisPhilip D Greenberg
May 4, 2013·The Lancet Oncology·Bodo E Lippitz
Oct 22, 2013·International Journal of Hematology·Wenjuan Yang, Yunxiao Xu
Aug 27, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James N KochenderferSteven A Rosenberg
Nov 20, 2014·The New England Journal of Medicine·Alexandra SnyderTimothy A Chan
Dec 9, 2014·The New England Journal of Medicine·Stephen M AnsellPhilippe Armand
Mar 25, 2015·American Journal of Hematology·Jason BrayerJavier Pinilla-Ibarz
Feb 26, 2016·Hematology·Siti-Zuleha IdrisMaha Abdullah
Dec 21, 2016·Cell Research·Atsushi Tanaka, Shimon Sakaguchi
Dec 22, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arend von StackelbergLia Gore
Jan 10, 2017·The Journal of Clinical Investigation·Cornelis A M van BergenJ H Frederik Falkenburg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.